23 filings
6-K
SPRC
SciSparc Ltd
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
6-K
SPRC
SciSparc Ltd
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
SPRC
SciSparc Ltd
3 Dec 19
Current report (foreign)
12:00am
6-K
SPRC
SciSparc Ltd
26 Nov 19
Report of Foreign Private Issuer
4:01pm
6-K
SPRC
SciSparc Ltd
19 Nov 19
Report of Foreign Private Issuer
8:33am
6-K
lanblw5t i2sv2c8v
13 Nov 19
Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program
4:07pm
6-K
12w mwo22e
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
5ti4 kbyya
15 Oct 19
Therapix Biosciences Announces Positive Data From Recent Pre-Clinical Study for New Drug Candidate THX-210
4:10pm
6-K
bpteaky
11 Oct 19
Current Report of Foreign Issuer
12:00am
6-K
soubf56utzhn05ht5ck
27 Aug 19
Current report (foreign)
4:13pm
6-K
dga2 70lkq52h
31 Jul 19
Therapix Biosciences Announces Canadian Product LicenseĀ Issuance for TheraPEA (CannAmideā¢), a Non-Opiate Based Pain Management Supplement
4:03pm
6-K
q7sy07aj5wjzcg8e9y
23 Jul 19
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a
4:05pm
6-K
nfoty jyqwpoqe
5 Jul 19
Therapix Biosciences Announces First Quarter 2019 Condensed Financial Data
6:08am
6-K
tc6afrfh
18 Jun 19
Therapix Biosciences Announces Interim Results of Phase IIa Study at Assuta Medical Center for Obstructive Sleep Apnea Program
4:09pm
6-K
7iz60pv4pjg63204833
29 May 19
Therapix Biosciences Issues Shareholder Update Letter
4:05pm
6-K
o7qa35fqyyc2rf
23 May 19
Therapix Biosciences Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Non-Compliance
5:02pm
6-K
cgvwreb 910w
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
fyk9jj
26 Mar 19
Report of Foreign Private Issuer
4:08pm
6-K
6u95gl4l481fnqfd
19 Mar 19
Therapix Biosciences Appoints Ambassador Ron Prosor as Executive Advisor
8:04am
6-K
hituvj85i4fvt smrqi
13 Mar 19
Report of Foreign Private Issuer
4:02pm